We are live on
!
Find out more
ACM
Atika Capital Management Portfolio holdings
AUM
$796M
1-Year Est. Return
167.57%
This Fund
S&P 500
This Quarter
Est. Return
-13.06%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$340M
AUM Growth
-$218M
(-39%)
Cap. Flow
-$143M
Cap. Flow
% of AUM
-42.21%
Top 10 Holdings %
Top 10 Hldgs %
34.54%
Holding
111
New
25
Increased
14
Reduced
28
Closed
40
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
COUP
Coupa Software Incorporated
COUP
|
+$4.05M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
+$3.23M |
| 3 |
Vulcan Materials
VMC
|
+$3.14M |
| 4 |
Vanda Pharmaceuticals
VNDA
|
+$3.06M |
| 5 |
iRhythm Holdings
IRTC
|
+$2.54M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HubSpot
HUBS
|
+$9.06M |
| 2 |
Shake Shack
SHAK
|
+$6.55M |
| 3 |
PVTL
Pivotal Software, Inc.
PVTL
|
+$6.46M |
| 4 |
WWE
World Wrestling Entertainment
WWE
|
+$5.8M |
| 5 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
+$5.42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.3% |
| 2 | Technology | 15.08% |
| 3 | Communication Services | 7.07% |
| 4 | Consumer Discretionary | 6.11% |
| 5 | Materials | 2.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $23.7M | 6.97% |
330,000
+80,000
| +32% | +$6.45M |
|
2
PUT
Invesco QQQ Trust
QQQ
$455B
| $17M | 4.99% |
110,000
-40,000
| -27% | -$6.69M |
|
3
PUT
Invesco Senior Loan ETF
BKLN
$7.1B
| $10.9M | 3.21% |
+500,000
| New | +$11.4M |
|
4
DexCom
DXCM
$27.6B
| $10.7M | 3.16% |
358,000
-110,000
| -24% | -$3.49M |
|
5
Atlanta Braves Holdings Series B
BATRK
$3.23B
| $9.96M | 2.93% |
400,000
-49,456
| -11% | -$1.25M |
|
|
EXAS
6
DELISTED
Exact Sciences
EXAS
| $9.5M | 2.8% |
150,500
+25,500
| +20% | +$1.75M |
|
7
Microsoft
MSFT
$2.84T
| $9.14M | 2.69% |
90,000
-9,000
| -9% | -$964K |
|
8
Intuitive Surgical
ISRG
$121B
| $9.1M | 2.68% |
57,000
-900
| -2% | -$153K |
|
9
Netflix
NFLX
$292B
| $8.83M | 2.6% |
330,000
+12,000
| +4% | +$359K |
|
10
Okta
OKTA
$24.1B
| $8.55M | 2.52% |
134,000
-4,000
| -3% | -$237K |
|
11
Sarepta Therapeutics
SRPT
$1.66B
| $8.52M | 2.51% |
78,100
-900
| -1% | -$113K |
|
12
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
| $8.11M | 2.39% |
+100,000
| New | +$8.37M |
|
13
eHealth
EHTH
$42.5M
| $7.68M | 2.26% |
200,000
+74,367
| +59% | +$2.5M |
|
14
RingCentral
RNG
$4.05B
| $7.09M | 2.09% |
86,000
-13,000
| -13% | -$1.02M |
|
|
ARNA
15
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $7.01M | 2.06% |
180,000
| – | – |
|
16
UnitedHealth
UNH
$382B
| $6.85M | 2.02% |
27,500
-2,300
| -8% | -$608K |
|
17
Elevance Health
ELV
$81.9B
| $6.7M | 1.97% |
25,500
+500
| +2% | +$137K |
|
|
GRA
18
DELISTED
W.R. Grace & Co.
GRA
| $6.43M | 1.89% |
99,000
+16,000
| +19% | +$1.03M |
|
19
CALL
Madison Square Garden
MSGS
$9.54B
| $6.29M | 1.85% |
+32,947
| New | +$6.41M |
|
20
Atlassian
TEAM
$22B
| – | – |
0
| – | – |
|
21
Amazon
AMZN
$2.5T
| $6.01M | 1.77% |
80,000
-33,000
| -29% | -$2.74M |
|
22
Inspire Medical Systems
INSP
$1.42B
| $5.7M | 1.68% |
135,000
+8,600
| +7% | +$366K |
|
|
23
CALL
Netflix
NFLX
$292B
| $5.35M | 1.58% |
+200,000
| New | +$5.99M |
|
24
New York Times
NYT
$11.6B
| $5.24M | 1.54% |
235,000
+87,300
| +59% | +$2.21M |
|
25
CALL
Neurocrine Biosciences
NBIX
$17.7B
| $5M | 1.47% |
+70,000
| New | +$6.71M |
|
Similar funds
AGA
ATS
RIM
ACM
CAM
LSA
GWA
Atika Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, Atika Capital Management held 111 positions worth $340M, down 39% from $558M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Atika Capital Management withdrew a net $143M in Q4 2018, closing 40 positions and reducing 28 holdings. Its most notable exit was HubSpot, an estimated $9.06M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 37% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Atika Capital Management opened a new position in Coupa Software Incorporated worth $4.02M.
- Atika Capital Management's largest Q4 2018 buy was Coupa Software Incorporated: 64,000 shares worth $4.02M.
- Atika Capital Management added most to eHealth in Q4 2018, an estimated $2.5M increase.
- Atika Capital Management's biggest Q4 2018 reduction was NovoCure, cutting an estimated $4.99M.
- Atika Capital Management fully exited HubSpot in Q4 2018, selling an estimated $9.06M.
- Atika Capital Management's ten largest holdings make up 35% of its $340M portfolio in Q4 2018.
- Atika Capital Management opened 25 new positions and closed 40 in Q4 2018.
- Atika Capital Management's portfolio value fell 39% quarter-over-quarter to $340M.
Based on Atika Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.